{"id":"https://openalex.org/W7202390831","doi":"https://doi.org/10.65801/pcp.3553","title":"After 25 Years of Experience: What Do We Know About Escitalopram?","display_name":"After 25 Years of Experience: What Do We Know About Escitalopram?","publication_year":2026,"publication_date":"2026-08-12","ids":{"openalex":"https://openalex.org/W7202390831","doi":"https://doi.org/10.65801/pcp.3553","pmid":"https://pubmed.ncbi.nlm.nih.gov/42964923","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13720856"},"language":"en","primary_location":{"id":"doi:10.65801/pcp.3553","doi":"https://doi.org/10.65801/pcp.3553","is_oa":true,"landing_page_url":"https://doi.org/10.65801/pcp.3553","pdf_url":"https://psychiatry-psychopharmacology.com/index.php/pub/article/download/3553/2274","source":{"id":"https://openalex.org/S4210198841","display_name":"Psychiatry and Clinical Psychopharmacology","issn_l":"2475-0573","issn":["2475-0573","2475-0581"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatry and Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://psychiatry-psychopharmacology.com/index.php/pub/article/download/3553/2274","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041772977","display_name":"G\u00f6zde \u00c7olak","orcid":"https://orcid.org/0009-0008-5675-4158","observed_orcids":["https://orcid.org/0009-0008-5675-4158","https://orcid.org/0000-0002-2170-4838"]},"institutions":[{"id":"https://openalex.org/I41641357","display_name":"Ege University","ror":"https://ror.org/02eaafc18","country_code":"TR","type":"education","lineage":["https://openalex.org/I41641357"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"G\u00f6zde \u00c7olak","raw_affiliation_strings":["SoCAT Lab, Department of Psychiatry, School of Medicine, Ege University, Izmir, T\u00fcrkiye"],"raw_orcid":"https://orcid.org/0009-0008-5675-4158","affiliations":[{"raw_affiliation_string":"SoCAT Lab, Department of Psychiatry, School of Medicine, Ege University, Izmir, T\u00fcrkiye","institution_ids":["https://openalex.org/I41641357"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027453910","display_name":"Ali Saffet G\u00f6n\u00fcl","orcid":"https://orcid.org/0000-0003-3522-1359","observed_orcids":["https://orcid.org/0000-0003-3522-1359"]},"institutions":[{"id":"https://openalex.org/I41641357","display_name":"Ege University","ror":"https://ror.org/02eaafc18","country_code":"TR","type":"education","lineage":["https://openalex.org/I41641357"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Ali Saffet G\u00f6n\u00fcl","raw_affiliation_strings":["SoCAT Lab, Department of Psychiatry, School of Medicine, Ege University, Izmir, T\u00fcrkiye"],"raw_orcid":"https://orcid.org/0000-0003-3522-1359","affiliations":[{"raw_affiliation_string":"SoCAT Lab, Department of Psychiatry, School of Medicine, Ege University, Izmir, T\u00fcrkiye","institution_ids":["https://openalex.org/I41641357"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5027453910"],"corresponding_institution_ids":["https://openalex.org/I41641357"],"apc_list":{"value":590,"currency":"USD","value_usd":590},"apc_paid":{"value":590,"currency":"USD","value_usd":590},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.34453333,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"4","first_page":"451","last_page":"461"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/escitalopram","display_name":"escitalopram","score":1.0},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9779999852180481},{"id":"https://openalex.org/keywords/serotonin-transporter","display_name":"serotonin transporter","score":0.847000002861023},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.7160000205039978},{"id":"https://openalex.org/keywords/anxiolytic-effects","display_name":"anxiolytic effects","score":0.9319999814033508},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.7929999828338623},{"id":"https://openalex.org/keywords/anxiety-disorders","display_name":"anxiety disorders","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8420000076293945},{"id":"https://openalex.org/keywords/fronto-limbic-network","display_name":"fronto-limbic network","score":0.8550000190734863},{"id":"https://openalex.org/keywords/qt-interval-prolongation","display_name":"QT prolongation","score":0.7279999852180481},{"id":"https://openalex.org/keywords/serotonin-syndrome","display_name":"serotonin syndrome","score":0.9300000071525574},{"id":"https://openalex.org/keywords/sexual-dysfunction","display_name":"sexual dysfunction","score":0.9520000219345093},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4860000014305115},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.6539999842643738},{"id":"https://openalex.org/keywords/cytochrome-p450-interactions","display_name":"cytochrome P450 interactions","score":0.8600000143051147},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.6079999804496765}],"concepts":[{"id":"https://openalex.org/C2779583969","wikidata":"https://www.wikidata.org/wiki/Q423757","display_name":"Escitalopram","level":4,"score":0.9521999955177307},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7009999752044678},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.6880000233650208},{"id":"https://openalex.org/C2778034309","wikidata":"https://www.wikidata.org/wiki/Q3563148","display_name":"Vortioxetine","level":4,"score":0.6000000238418579},{"id":"https://openalex.org/C2777490545","wikidata":"https://www.wikidata.org/wiki/Q409672","display_name":"Citalopram","level":4,"score":0.5449000000953674},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.5199999809265137},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.5033000111579895},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.49729999899864197},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.48590001463890076},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.47929999232292175},{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.46549999713897705},{"id":"https://openalex.org/C2778897192","wikidata":"https://www.wikidata.org/wiki/Q410142","display_name":"Serotonin transporter","level":4,"score":0.4458000063896179},{"id":"https://openalex.org/C2776809841","wikidata":"https://www.wikidata.org/wiki/Q185935","display_name":"Mania","level":4,"score":0.4327000081539154},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4316999912261963},{"id":"https://openalex.org/C2779911313","wikidata":"https://www.wikidata.org/wiki/Q845224","display_name":"Generalized anxiety disorder","level":3,"score":0.42419999837875366},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4043999910354614},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.40400001406669617},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.38999998569488525},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.37630000710487366},{"id":"https://openalex.org/C2777529043","wikidata":"https://www.wikidata.org/wiki/Q741713","display_name":"Panic disorder","level":3,"score":0.3720000088214874},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3621000051498413},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.361299991607666},{"id":"https://openalex.org/C2781210005","wikidata":"https://www.wikidata.org/wiki/Q6738337","display_name":"Major depressive episode","level":3,"score":0.3440999984741211},{"id":"https://openalex.org/C2776701107","wikidata":"https://www.wikidata.org/wiki/Q416992","display_name":"Lurasidone","level":4,"score":0.29789999127388},{"id":"https://openalex.org/C2776466888","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine","level":4,"score":0.2944999933242798},{"id":"https://openalex.org/C2777545354","wikidata":"https://www.wikidata.org/wiki/Q3557657","display_name":"Social anxiety","level":3,"score":0.2847000062465668},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.26420000195503235},{"id":"https://openalex.org/C2777134132","wikidata":"https://www.wikidata.org/wiki/Q188638","display_name":"Mood disorders","level":3,"score":0.2581999897956848},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.2526000142097473}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.65801/pcp.3553","doi":"https://doi.org/10.65801/pcp.3553","is_oa":true,"landing_page_url":"https://doi.org/10.65801/pcp.3553","pdf_url":"https://psychiatry-psychopharmacology.com/index.php/pub/article/download/3553/2274","source":{"id":"https://openalex.org/S4210198841","display_name":"Psychiatry and Clinical Psychopharmacology","issn_l":"2475-0573","issn":["2475-0573","2475-0581"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatry and Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13720856","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13720856/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13720856/pdf/pcp-36-4-451.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatry Clin Psychopharmacol","raw_type":"Text"},{"id":"pmh:oai:oai.psychiatry-psychopharmacology.com:article/3553","doi":null,"is_oa":true,"landing_page_url":"https://psychiatry-psychopharmacology.com/index.php/pub/article/view/3553","pdf_url":null,"source":{"id":"https://openalex.org/S4210198841","display_name":"Psychiatry and Clinical Psychopharmacology","issn_l":"2475-0573","issn":["2475-0573","2475-0581"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2475-0581","raw_type":"info:eu-repo/semantics/article"},{"id":"pmid:42964923","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42964923","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatry and clinical psychopharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:b7e8af9903544aaa83ef85f692f99efa","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/b7e8af9903544aaa83ef85f692f99efa","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Psychiatry and Clinical Psychopharmacology, Vol 36, Iss 4 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.65801/pcp.3553","doi":"https://doi.org/10.65801/pcp.3553","is_oa":true,"landing_page_url":"https://doi.org/10.65801/pcp.3553","pdf_url":"https://psychiatry-psychopharmacology.com/index.php/pub/article/download/3553/2274","source":{"id":"https://openalex.org/S4210198841","display_name":"Psychiatry and Clinical Psychopharmacology","issn_l":"2475-0573","issn":["2475-0573","2475-0581"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychiatry and Clinical Psychopharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7202390831.pdf","grobid_xml":"https://content.openalex.org/works/W7202390831.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1788141403","https://openalex.org/W1964317019","https://openalex.org/W1982377331","https://openalex.org/W1986777050","https://openalex.org/W1993067969","https://openalex.org/W2018008180","https://openalex.org/W2021113657","https://openalex.org/W2022082295","https://openalex.org/W2027216150","https://openalex.org/W2028458346","https://openalex.org/W2031385069","https://openalex.org/W2033309297","https://openalex.org/W2035444856","https://openalex.org/W2055897579","https://openalex.org/W2058750823","https://openalex.org/W2140107414","https://openalex.org/W2145806711","https://openalex.org/W2148239264","https://openalex.org/W2148624863","https://openalex.org/W2151845762","https://openalex.org/W2158392145","https://openalex.org/W2169083980","https://openalex.org/W2597065179","https://openalex.org/W2788337440","https://openalex.org/W2948548704","https://openalex.org/W3017335805","https://openalex.org/W3192281797","https://openalex.org/W4236825903","https://openalex.org/W4386960927","https://openalex.org/W4388966609","https://openalex.org/W4394824163","https://openalex.org/W4409171420"],"related_works":["https://openalex.org/W2012549547","https://openalex.org/W2070539523","https://openalex.org/W2113549328","https://openalex.org/W2126068921","https://openalex.org/W2053701135","https://openalex.org/W2158910272","https://openalex.org/W2554873270","https://openalex.org/W2119000485","https://openalex.org/W2389308911","https://openalex.org/W2140344207"],"abstract_inverted_index":{"Escitalopram,":[0],"the":[1,9,19,32,96],"S-enantiomer":[2],"of":[3,8,21,59,65,102,118,201],"racemic":[4],"citalopram,":[5],"is":[6,169],"one":[7,98],"most":[10,174],"widely":[11],"prescribed":[12],"selective":[13],"serotonin":[14,33,188],"reuptake":[15],"inhibitors":[16],"(SSRIs)":[17],"for":[18,31,163,215],"treatment":[20,214,239],"depressive":[22,217],"and":[23,36,72,79,87,116,133,136,140,155,166,179,187,219,228],"anxiety":[24,220],"disorders.":[25,221],"Owing":[26],"to":[27,99,143,160],"its":[28,37,63,108,161,193,233],"high":[29],"selectivity":[30],"transporter":[34],"(SERT)":[35],"unique":[38],"allosteric":[39],"binding":[40],"properties,":[41],"escitalopram":[42,83,129,209],"demonstrates":[43],"pharmacological":[44,213,223],"characteristics":[45],"that":[46,82,200],"distinguish":[47],"it":[48],"from":[49,75],"other":[50,144,202],"SSRIs.":[51,203],"This":[52],"narrative":[53],"review":[54],"provides":[55],"an":[56],"up-to-date":[57],"evaluation":[58],"escitalopram,":[60],"focusing":[61],"on":[62],"mechanism":[64],"action,":[66],"pharmacokinetic":[67,148],"profile,":[68],"clinical":[69,191,226],"efficacy,":[70,227],"tolerability,":[71],"safety.":[73],"Evidence":[74],"randomized":[76],"controlled":[77],"trials":[78],"meta-analyses":[80],"indicates":[81],"produces":[84],"significant":[85],"antidepressant":[86,145],"anxiolytic":[88],"effects,":[89],"with":[90,123,173,199],"symptom":[91],"improvement":[92],"often":[93],"observed":[94],"within":[95],"first":[97],"two":[100],"weeks":[101],"treatment.":[103],"Neuroimaging":[104],"studies":[105],"further":[106],"support":[107],"therapeutic":[109],"activity":[110],"by":[111],"demonstrating":[112],"dose-dependent":[113],"SERT":[114],"occupancy":[115],"normalization":[117],"fronto-limbic":[119],"network":[120],"dysfunction":[121],"associated":[122],"mood":[124],"regulation.":[125],"In":[126,204],"comparative":[127],"studies,":[128],"yields":[130],"favorable":[131,229],"response":[132],"remission":[134],"rates":[135],"exhibits":[137],"better":[138],"acceptability":[139],"tolerability":[141,230],"relative":[142],"agents.":[146],"Its":[147,222],"properties-including":[149],"predictable":[150],"absorption,":[151],"linear":[152],"dose-concentration":[153],"relationships,":[154],"limited":[156],"cytochrome":[157],"P450":[158],"interactions-contribute":[159],"suitability":[162],"long-term":[164],"use":[165],"polypharmacy.":[167],"Escitalopram":[168],"generally":[170],"well":[171],"tolerated,":[172],"adverse":[175],"effects":[176],"being":[177],"mild":[178],"transient.":[180],"Although":[181],"sexual":[182],"dysfunction,":[183],"QT":[184],"interval":[185],"prolongation,":[186],"syndrome":[189],"remain":[190],"considerations,":[192],"overall":[194],"safety":[195],"profile":[196,231],"compares":[197],"favorably":[198],"conclusion,":[205],"current":[206],"evidence":[207],"supports":[208],"as":[210],"a":[211],"first-line":[212],"major":[216],"disorder":[218],"specificity,":[224],"consistent":[225],"reinforce":[232],"central":[234],"role":[235],"in":[236],"contemporary":[237],"psychiatric":[238],"strategies.":[240]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-08-14T00:00:00"}